<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on August 9, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>FORM S-8</B><BR>
<BR>
</FONT><FONT STYLE="font-size: 10pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BAUSCH HEALTH COMPANIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><B>British Columbia, Canada<BR>
(State or Other Jurisdiction of<BR>
Incorporation or Organization)</B></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="background-color: white"><B>98-0448205</B></FONT><B><BR>
(I.R.S. Employer<BR>
Identification No.)</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2150 St. Elz&eacute;ar Blvd. West<BR>
    Laval, Quebec<BR>
    Canada, H7L 4A8 </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(514) 744-6792<BR>
    (<FONT STYLE="font-size: 10pt">Address, including zip code, and telephone number, including area code, of Registrant&rsquo;s principal
    executive offices</FONT>)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BAUSCH HEALTH COMPANIES INC.<BR>
AMENDED AND RESTATED 2014 OMNIBUS INCENTIVE PLAN<BR>
<FONT STYLE="font-weight: normal">(Full Title of the Plan)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tom G. Vadaketh</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Executive Vice President, Chief Financial Officer</B><BR>
<B>Bausch Health Companies Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>c/o Bausch Health US, LLC</B><BR>
<B>400 Somerset Corporate Blvd.</B><BR>
<B>Bridgewater, NJ 08807</B><BR>
<B>(866) 246-8245</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: yellow"><BR>
</FONT><FONT STYLE="font-weight: normal">(Name, address and telephone number,<BR>
including area code, of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
&ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth
company&rdquo; in Rule 12b-2 of the Exchange Act.<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 68%; font-size: 10pt"><B>Large accelerated filer &#9746;</B></TD>
    <TD STYLE="width: 32%; font-size: 10pt"><B>Accelerated filer </B>&#9744;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><B>Non-accelerated filer </B>&#9744;<B>&nbsp;(Do not check if a smaller reporting company)</B></TD>
    <TD STYLE="font-size: 10pt"><B>Smaller reporting company </B>&#9744;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><B>Emerging Growth Company </B>&#9744;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXPLANATORY NOTE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">This Registration Statement has
been prepared and filed pursuant to and in accordance with the requirements of General Instruction E to Form S-8 for the purpose of registering
an additional 11,500,000 Common Shares, no par value (&ldquo;Common Shares&rdquo;), of Bausch Health Companies Inc. (the &ldquo;Company&rdquo;
or &ldquo;Registrant&rdquo;) that are issuable at any time or from time to time under the Bausch Health Companies Inc. Amended and Restated
2014 Omnibus Incentive Plan, as amended and restated effective as of June 21, 2022 (the &ldquo;Plan&rdquo;),</FONT> and any additional
Common Shares that become issuable under the Plan by reason of any stock dividend, stock split, or other similar transaction pursuant
to Rule 416(a) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Pursuant to General Instruction
E, the contents of the Registration Statements on Form S-8 filed for the Plan with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
on May 21, 2014 (Registration No. 333-196120), August 10, 2018 (Registration No. 333-226786) and May 7, 2020 (Registration No. 333-226786),
including the documents incorporated by reference therein, are incorporated by reference into this Registration Statement on Form S-8
(this &ldquo;Registration Statement&rdquo;), except as supplemented by the information set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I<BR>
&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The information specified in Item 1 and Item 2
of Part I of Form S-8 is omitted from this filing in accordance with the provisions of Rule 428 under the Securities Act and the introductory
note to Part I of the Form S-8 instructions. The document containing the information specified in Part I will be delivered to the participants
in the Plan as required by Rule 428(b)(1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 3. Incorporation of Documents by Reference</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following documents previously filed with
the Commission are incorporated herein by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;The Company&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Commission on February 23, 2022 (Registration No.
001-14956)(except for the information set forth in Items 7 and 15(a)(1) thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b) The Company&rsquo;s Quarterly Reports on Form
10-Q for the quarter ended March 31, 2022, filed with the Commission on May 10, 2022 and for the quarter ended June 30, 2022, filed with
the Commission on August 9, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c) The Company&rsquo;s Current Reports on Form
8-K filed on January 13, 2022 (except with respect to Item 7.01), January 18, 2022, January 27, 2022, February 10, 2022 (except with respect
to Item 7.01), March 31, 2022, April 4, 2022, April 28, 2022 (except with respect to Item 2.02), May 10, 2022, May 11, 2022, May 31, 2022,
June 3, 2022, June 24, 2022, June 24, 2022 and July 29, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&nbsp; The description of the Common Shares
contained in the Company&rsquo;s Registration Statement on Form 8-A12B/A filed with the Commission on May 20, 2014 and any amendment or
report filed for the purpose of updating such description.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, all documents subsequently filed
by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of the filing of such documents. Any statement contained in a document incorporated or
deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">modifies
or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 5. Interests of Named Experts and Counsel</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 8. Exhibits</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; width: 9%; padding-bottom: 3pt"><B>Exhibit<BR>
Number</B></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; width: 2%; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; width: 89%; text-align: center; padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000119312513331879/d583672dex31.htm">4.1</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; text-align: center; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000119312513331879/d583672dex31.htm">Certificate of Continuation, dated August 9, 2013, originally filed as Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on August 13, 2013*</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0301.htm">4.2</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0301.htm">Notice of Articles of Bausch Health Companies Inc., as of July 16, 2018, filed as Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on July 16, 2018*</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0302.htm">4.3</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0302.htm">Articles of the Company, as of July 13, 2018 and dated August 8, 2013, filed as Exhibit 3.2 to the Company&rsquo;s Current Report on Form 8-K filed on July 16, 2018*</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex0501.htm">5.1</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex0501.htm">Opinion of Osler, Hoskin &amp; Harcourt LLP</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex2301.htm">23.1</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex2301.htm">Consent of PricewaterhouseCoopers LLP</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex0501.htm">23.2</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex0501.htm">Consent of Osler, Hoskin &amp; Harcourt LLP (included in Exhibit 5.1)</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="#poa">24.1</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="#poa">Power of Attorney (included on the signature pages of this Registration Statement)</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex9901.htm">99.1</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_ex9901.htm">Bausch Health Companies Inc. Amended and Restated 2014 Omnibus Incentive Plan, amended and restated effective as of June 21, 2022</A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_exfilingfees.htm">107</A></TD>
    <TD STYLE="padding-top: 3pt; vertical-align: bottom; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; vertical-align: top; padding-bottom: 3pt"><A HREF="dp178483_exfilingfees.htm">Calculation of filing fee table</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">*Incorporated herein by reference</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the United
States, in the township of Bridgewater, State of New Jersey, on August 9, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BAUSCH HEALTH COMPANIES INC. </B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 29%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 4%">By:</TD>
    <TD STYLE="vertical-align: top; width: 38%; border-bottom: Black 1pt solid"><I>/s/ Thomas J. Appio</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Thomas J. Appio</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><I>Chief Executive Officer </I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><I>(Principal Executive Officer)</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BAUSCH HEALTH US, LLC, <BR>
as Authorized Representative in the United States </B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">By:</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><I>/s/ Tom G. Vadaketh</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Tom G. Vadaketh</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Executive Vice President, Chief Financial Officer</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>on behalf of Bausch Health US, LLC </I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><A NAME="poa"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The undersigned directors and officers of Bausch
Health Companies Inc. hereby appoint each of Thomas J. Appio and Tom Vadaketh as attorneys-in-fact for the undersigned, with full power
of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission
under the Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this registration statement
on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under
the Securities Act of 1933) and any and all applications and other documents to be filed with the Securities and Exchange Commission pertaining
to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and things whatsoever
requisite and necessary or desirable, hereby ratifying and confirming all that said attorney-in-fact, or his her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Pursuant to the requirements of the Securities Act
of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 40%">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid">Signature&nbsp;</P></TD>
    <TD STYLE="padding-right: 2pt; vertical-align: bottom; width: 31%; padding-left: 2pt">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid">Title&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; width: 29%">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid">Date&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Thomas J. Appio&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Chief Executive Officer and Director<BR>
(Principal Executive Officer)</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 9.35pt; text-indent: -9.35pt">Thomas J. Appio</TD>
    <TD STYLE="padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in; border-bottom: Black 0.5pt solid"><I>/s/ Tom
G. Vadaketh&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; padding-left: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Executive Vice President,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Financial Officer<BR>
(Principal Financial Officer)&nbsp;</P></TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 9.35pt; text-indent: -9.35pt">Tom G. Vadaketh</TD>
    <TD STYLE="padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
John S. Barresi&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Senior Vice President, Controller and Chief Accounting Officer (Principal Accounting Officer)</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 9.35pt; text-indent: -9.35pt">John S. Barresi</TD>
    <TD STYLE="padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in; border-bottom: Black 0.5pt solid"><I>/s/ John
A. Paulson&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Chairman of the Board</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>John A. Paulson</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Richard U. De Schutter&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Richard U. De Schutter</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Brett Icahn&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Brett Icahn</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in; border-bottom: Black 0.5pt solid"><I>/s/ Dr.
Argeris N. Karabelas&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Dr. Argeris N. Karabelas</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Sarah B. Kavanagh</I></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Sarah B. Kavanagh</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><I>/s/ Steven D. Miller</I></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: Black 1pt solid; padding-left: 9.35pt; text-indent: -9.35pt">Steven D. Miller</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Dr. Richard C. Mulligan&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Dr. Richard C. Mulligan</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Robert N. Power</I></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Robert N. Power</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Russel C. Robertson&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Russel C. Robertson</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Thomas W. Ross, Sr.&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;Thomas W. Ross, Sr.</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><I>/s/
Amy B. Wechsler, M.D.&nbsp;</I></P></TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">Director</TD>
    <TD STYLE="text-align: center">August 9, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 9.35pt; text-indent: -9.35pt">Amy B. Wechsler, M.D.</TD>
    <TD STYLE="padding-right: 2pt; text-align: center; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "dp178483_s8.htm", "description": "FORM S-8", "secsgml_size_bytes": 40101}]
{"company-data": {"conformed-name": "Bausch Health Companies Inc.", "cik": "0000885590", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "NJ", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-266718", "film-number": "221149298"}, "business-address": {"street1": "2150 ST. ELZEAR BLVD. WEST", "street2": "LAVAL", "city": "QUEBEC", "state": "A8", "zip": "H7L 4A8", "phone": "514-744-6792"}, "mail-address": {"street1": "2150 ST. ELZEAR BLVD. WEST", "street2": "LAVAL", "city": "QUEBEC", "state": "A8", "zip": "H7L 4A8"}, "former-company": [{"former-conformed-name": "Valeant Pharmaceuticals International, Inc.", "date-changed": "20100928"}, {"former-conformed-name": "BIOVAIL Corp", "date-changed": "20100416"}, {"former-conformed-name": "BIOVAIL CORP INTERNATIONAL", "date-changed": "19960522"}]}
As filed with the Securities and Exchange Commission
on August 9, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
BAUSCH HEALTH COMPANIES INC.
(Exact Name of Registrant as Specified in Its Charter)
British Columbia, Canada
(State or Other Jurisdiction of
Incorporation or Organization)
98-0448205
(I.R.S. Employer
Identification No.)
2150 St. Elzéar Blvd. West
Laval, Quebec
Canada, H7L 4A8
(514) 744-6792
(
Address, including zip code, and telephone number, including area code, of Registrant's principal
    executive offices
)
BAUSCH HEALTH COMPANIES INC.
AMENDED AND RESTATED 2014 OMNIBUS INCENTIVE PLAN
(Full Title of the Plan)
Tom G. Vadaketh
Executive Vice President, Chief Financial Officer
Bausch Health Companies Inc.
c/o Bausch Health US, LLC
400 Somerset Corporate Blvd.
Bridgewater, NJ 08807
(866) 246-8245
(Name, address and telephone number,
including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
"large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth
company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒
Accelerated filer
☐
Non-accelerated filer
☐
(Do not check if a smaller reporting company)
Smaller reporting company
☐
Emerging Growth Company
☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement has
been prepared and filed pursuant to and in accordance with the requirements of General Instruction E to Form S-8 for the purpose of registering
an additional 11,500,000 Common Shares, no par value ("Common Shares"), of Bausch Health Companies Inc. (the "Company"
or "Registrant") that are issuable at any time or from time to time under the Bausch Health Companies Inc. Amended and Restated
2014 Omnibus Incentive Plan, as amended and restated effective as of June 21, 2022 (the "Plan"),
and any additional
Common Shares that become issuable under the Plan by reason of any stock dividend, stock split, or other similar transaction pursuant
to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act").
Pursuant to General Instruction
E, the contents of the Registration Statements on Form S-8 filed for the Plan with the Securities and Exchange Commission (the "Commission")
on May 21, 2014 (Registration No. 333-196120), August 10, 2018 (Registration No. 333-226786) and May 7, 2020 (Registration No. 333-226786),
including the documents incorporated by reference therein, are incorporated by reference into this Registration Statement on Form S-8
(this "Registration Statement"), except as supplemented by the information set forth below.
PART I
The information specified in Item 1 and Item 2
of Part I of Form S-8 is omitted from this filing in accordance with the provisions of Rule 428 under the Securities Act and the introductory
note to Part I of the Form S-8 instructions. The document containing the information specified in Part I will be delivered to the participants
in the Plan as required by Rule 428(b)(1).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference
The following documents previously filed with
the Commission are incorporated herein by reference:
(a)   The Company's
Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Commission on February 23, 2022 (Registration No.
001-14956)(except for the information set forth in Items 7 and 15(a)(1) thereof).
(b) The Company's Quarterly Reports on Form
10-Q for the quarter ended March 31, 2022, filed with the Commission on May 10, 2022 and for the quarter ended June 30, 2022, filed with
the Commission on August 9, 2022.
(c) The Company's Current Reports on Form
8-K filed on January 13, 2022 (except with respect to Item 7.01), January 18, 2022, January 27, 2022, February 10, 2022 (except with respect
to Item 7.01), March 31, 2022, April 4, 2022, April 28, 2022 (except with respect to Item 2.02), May 10, 2022, May 11, 2022, May 31, 2022,
June 3, 2022, June 24, 2022, June 24, 2022 and July 29, 2022.
(d)  The description of the Common Shares
contained in the Company's Registration Statement on Form 8-A12B/A filed with the Commission on May 20, 2014 and any amendment or
report filed for the purpose of updating such description.
In addition, all documents subsequently filed
by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of the filing of such documents. Any statement contained in a document incorporated or
deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein),
modifies
or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.
Item 5. Interests of Named Experts and Counsel
Not applicable.
Item 8. Exhibits
Exhibit
Number
4.1
Certificate of Continuation, dated August 9, 2013, originally filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed on August 13, 2013*
4.2
Notice of Articles of Bausch Health Companies Inc., as of July 16, 2018, filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed on July 16, 2018*
4.3
Articles of the Company, as of July 13, 2018 and dated August 8, 2013, filed as Exhibit 3.2 to the Company's Current Report on Form 8-K filed on July 16, 2018*
5.1
Opinion of Osler, Hoskin & Harcourt LLP
23.1
Consent of PricewaterhouseCoopers LLP
23.2
Consent of Osler, Hoskin & Harcourt LLP (included in Exhibit 5.1)
24.1
Power of Attorney (included on the signature pages of this Registration Statement)
99.1
Bausch Health Companies Inc. Amended and Restated 2014 Omnibus Incentive Plan, amended and restated effective as of June 21, 2022
107
Calculation of filing fee table
*Incorporated herein by reference
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the United
States, in the township of Bridgewater, State of New Jersey, on August 9, 2022.
BAUSCH HEALTH COMPANIES INC.
By:
/s/ Thomas J. Appio
Thomas J. Appio
Chief Executive Officer
(Principal Executive Officer)
BAUSCH HEALTH US, LLC,
as Authorized Representative in the United States
By:
/s/ Tom G. Vadaketh
Tom G. Vadaketh
Executive Vice President, Chief Financial Officer
on behalf of Bausch Health US, LLC
POWER OF ATTORNEY
The undersigned directors and officers of Bausch
Health Companies Inc. hereby appoint each of Thomas J. Appio and Tom Vadaketh as attorneys-in-fact for the undersigned, with full power
of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission
under the Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this registration statement
on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under
the Securities Act of 1933) and any and all applications and other documents to be filed with the Securities and Exchange Commission pertaining
to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and things whatsoever
requisite and necessary or desirable, hereby ratifying and confirming all that said attorney-in-fact, or his her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act
of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Thomas J. Appio
Chief Executive Officer and Director
(Principal Executive Officer)
August 9, 2022
Thomas J. Appio
/s/ Tom
G. Vadaketh
Executive Vice President,
Chief Financial Officer
(Principal Financial Officer)
August 9, 2022
Tom G. Vadaketh
/s/
John S. Barresi
Senior Vice President, Controller and Chief Accounting Officer (Principal Accounting Officer)
August 9, 2022
John S. Barresi
/s/ John
A. Paulson
Chairman of the Board
August 9, 2022
John A. Paulson
/s/
Richard U. De Schutter
Director
August 9, 2022
Richard U. De Schutter
/s/
Brett Icahn
Director
August 9, 2022
Brett Icahn
/s/ Dr.
Argeris N. Karabelas
Director
August 9, 2022
Dr. Argeris N. Karabelas
/s/ Sarah B. Kavanagh
Director
August 9, 2022
Sarah B. Kavanagh
/s/ Steven D. Miller
Director
August 9, 2022
Steven D. Miller
/s/
Dr. Richard C. Mulligan
Director
August 9, 2022
Dr. Richard C. Mulligan
/s/ Robert N. Power
Director
August 9, 2022
Robert N. Power
/s/
Russel C. Robertson
Director
August 9, 2022
Russel C. Robertson
/s/
Thomas W. Ross, Sr.
Director
August 9, 2022
Thomas W. Ross, Sr.
/s/
Amy B. Wechsler, M.D.
Director
August 9, 2022
Amy B. Wechsler, M.D.